Appointment of first Chief Medical Officer, Chief Information Officer, Chief People officer Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore based molecular sensing, today announces the appointments of Davide Manissero MD as Chief Medical Officer, Andrew Watson as Chief Information Officer and the joining of Tina St Leger as Chief […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory. In this role, Mr. Porreca is responsible for leading quality assurance, quality systems […]

Company appoints Sam Ropp as Chief Commercial Officer and Susan Tousi to Board of Directors BOSTON — Atrandi Biosciences, a life science tools company pioneering Semi-Permeable Capsule (SPC) technology for single-cell and multiomics research, today announced the appointment of Sam Ropp, PhD, as Chief Commercial Officer and Susan Tousi as Chairman of the Board of Directors. […]

FREMONT, Calif. — Ultima Genomics today announced Francisco De La Vega, DSc, has joined the Company as Vice President, Germline Genomics & Distinguished Scientific Fellow. With over 25 years of leadership experience in human genetics, computational biology, and bioinformatics, Francisco will drive Ultima’s inherited genome analysis applications to unlock insights into genetic diseases, population health, […]

Basel, Switzerland — Swiss Rockets today announced the appointment of Dana Novac, MD, MA, as Chief Medical Officer (CMO). Dr. Novac previously served as Senior Medical Director at Swiss Rockets AG, where she led oncology and dermatology clinical development programs and contributed to the broader clinical strategy across the company’s portfolio. Dr. Novac succeeds Bruno […]

BOSTON — Stellaromics, Inc., a leader in 3D spatial multi-omics, today announced two key additions to its executive leadership team: Veronica Mankinen as Senior Vice President of Global Commercial Operations and John Leamon, Ph.D., as Senior Vice President of Product Development. These strategic appointments come as the company ramps up the commercial launch of its Pyxa® […]

BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer (“CFO”) will depart the Company. A search for her successor is ongoing, and Ms. Sriram will continue as CFO through June 15, 2026, to ensure continuity and a successful transition. “Vandana has […]

Genovis AB announces that Chief Financial Officer (CFO) Magnus Långberg has decided to leave the company to pursue a new opportunity outside the Group. Magnus Långberg will remain in his current role during a transition period to ensure a structured handover to his successor. Johan Dahlberg has been appointed as the new Chief Financial Officer […]

SAN DIEGO — MileCell Biotechnology (“MileCell”) today announced the launch of its newly redesigned website www.milecell-bio.com, delivering an enhanced digital experience for researchers and industry partners worldwide. The company also announced the appointments of Nianwei Lin, PhD, Chief Executive Officer and Wayne Vaz, Chief Commercial Officer. The new website was developed to improve usability, streamline product […]

Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® Product Suite REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced the appointment of Anthony Bazarko as Chief Commercial Officer. Mr. Bazarko brings more than two decades […]